AAV Vector Segmentation for CRISPR Gene Insertion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene therapy methods for treating monogenic diseases like lysosomal storage disorders and hemophilia face challenges in achieving long-term therapeutic benefits with minimal safety risks and off-target effects, particularly in delivering CRISPR/Cas systems effectively to hepatocytes for systemic and neurological diseases.
Innovation Solution
The use of CRISPR/Cas9 mediated genome editing via AAV vectors targeting the albumin locus for homology-directed repair, with SaCas9 and guide RNAs, to insert therapeutic genes like IDUA or HEXB, achieving high specificity and efficiency with reduced off-target events and vector doses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If CRISPR/Cas systems are delivered via viral vectors to achieve targeted genome editing, then therapeutic gene insertion efficiency is improved, but off-target effects and safety risks increase
Solution Approach 1:
The CRISPR/Cas system is divided into multiple separate AAV vectors: one vector delivers Cas9 protein, another delivers guide RNA, and a third delivers the therapeutic gene with homology arms. This segmentation allows each component to be optimized independently and reduces the risk of off-target effects by controlling the timing and location of gene delivery
Solution Approach 2:
Homology arms serve as intermediary sequences that mediate precise integration of the therapeutic gene into the target genomic locus. These homology arms guide the integrated repair process to ensure accurate insertion at the intended site, thereby minimizing off-target effects while maintaining high insertion efficiency
2Reliability
If high doses of viral vectors are used to ensure sufficient gene delivery, then therapeutic effect is improved, but insertional mutagenesis risks increase
Solution Approach 1:
Dividing the gene therapy into multiple vectors reduces the viral dose required for each individual vector, thereby maintaining therapeutic efficacy while minimizing the risk of insertional mutagenesis associated with high-dose single-vector approaches
Solution Approach 2:
The use of homology-directed repair mechanisms allows the cell's own repair machinery to facilitate precise gene insertion at the target locus, reducing reliance on high-dose viral vectors and minimizing random integration events that could lead to insertional mutagenesis
3Object-affected harmful factors
If multiple vectors are used to deliver CRISPR components separately, then off-target effects are reduced, but delivery complexity increases
Solution Approach 1:
Each AAV vector is engineered to perform multiple functions: delivering genetic material, targeting specific cell types through tropism, and enabling controlled expression of CRISPR components. This multi-functionality simplifies the overall delivery system despite using multiple vectors, as each vector is optimized to handle multiple aspects of the gene therapy process
Data Source
AI summary
Compositions and methods for Cas-based ex vivo and in vivo gene therapy applications are provided.